Pacira Biosciences Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pacira Biosciences Inc with three other
companies in this sector in UNITED STATES :
Ironwood Pharmaceuticals Incorporation
(2020
sales of $389.52 million
of which 100%
was human therapeutics.),
Acadia Pharmaceuticals, Inc.
($441.76 million
of which 100%
was Molecular Drugs), and
Natures Sunshine Products Inc
($385.21 million
).
Sales Analysis.
Pacira Biosciences Inc reported sales of $429.65 million
for the
year ending
December of 2020.
This
represents
an
increase of 2.0%
versus 2019, when the company's sales were $421.03 million.
Sales at Pacira Biosciences Inc have increased during each of the previous five years
(and since 2015, sales have increased a total of 73%).